Fmoc-(3S,4S)-AHPPA-OH

Fmoc-(3S,4S)-AHPPA-OH is an Fmoc-protected, chiral amino acid derivative bearing the (3S,4S) stereochemical configuration within its side-chain framework and terminating in a free carboxylic acid for peptide coupling. The molecule combines an Fmoc carbamate on the amino functionality with a stereogenic, amino acid-like scaffold that can present defined three-dimensional geometry to acylation and amide bond formation. The presence of a free carboxyl group enables conversion to activated esters or direct incorporation into peptide sequences, while the Fmoc group supports standard base-labile protection/deprotection workflows used in solid-phase synthesis. The side-chain architecture, controlled by the (3S,4S) stereocenters, can influence conformational preferences and downstream derivatization chemistry relevant to peptidomimetic and structure-guided design.

1. Peptide Synthesis

Fmoc-(3S,4S)-AHPPA-OH is applied in peptide building-block preparation for solution-phase and solid-phase peptide synthesis workflows where orthogonal protection and reliable coupling are required. The Fmoc-protected amine participates in standard peptide coupling after Fmoc deprotection, while the free carboxylic acid provides the reactive handle for forming amide bonds with activated carboxyl partners. The (3S,4S) stereochemical definition supports stereochemically controlled incorporation into peptide chains, enabling residue-level studies of backbone and side-chain geometry. Downstream, the resulting peptide products can be used as synthetic intermediates for analog libraries and as substrates for biochemical assays that probe sequence-dependent recognition.

2. Peptidomimetics And SAR Studies

Fmoc-(3S,4S)-AHPPA-OH serves in peptidomimetic construction and structure-activity relationship studies where stereodefined amino acid analogs help map conformational and functional contributions. The chiral side-chain features and the amino acid-like connectivity enable incorporation into constrained scaffolds that can modulate local orientation of functional groups within a larger ligand. The Fmoc strategy supports iterative assembly of analog series, allowing systematic variation of neighboring residues while retaining the (3S,4S) configuration at the modified position. Resulting analogs can be used as research-grade intermediates for SAR-focused synthesis, fragment elaboration, and conformational profiling campaigns in medicinal chemistry.

3. Chemical Biology Labeling

Fmoc-(3S,4S)-AHPPA-OH can be utilized in chemical biology for generating amino acid-derived probes and tagged peptide fragments that maintain stereochemical fidelity. The free carboxyl group enables conversion to activated derivatives suitable for conjugation to amine-bearing targets or for incorporation into larger labeling constructs, while the Fmoc group provides a protected stage during assembly of probe-bearing sequences. The defined stereochemistry can be important when binding-site recognition depends on three-dimensional shape, supporting the preparation of stereochemically matched conjugates. Downstream applications include preparing labeled peptide intermediates for biomolecule interaction studies and for building blocks used in multistep bioconjugation schemes.

4. Protected Amino Acid Intermediate

Fmoc-(3S,4S)-AHPPA-OH functions as a protected amino acid intermediate in fine chemical synthesis where Fmoc-based protection enables controlled reactivity during multi-functional transformations. The Fmoc carbamate masks the amino group to prevent side reactions during carboxyl activation or coupling steps, while the free acid allows selective downstream conversion to peptide-ready forms or other carboxyl-derived derivatives. The chiral (3S,4S) configuration is preserved through Fmoc-compatible synthetic operations, supporting stereochemical integrity across manufacturing or research-scale preparations. The compound can therefore be employed to produce a range of downstream amino acid derivatives, including activated carboxyl intermediates and peptide building blocks used in iterative synthesis.

5. Process Chemistry Intermediate

Fmoc-(3S,4S)-AHPPA-OH is suitable for process chemistry intermediate preparation in industrial settings that rely on robust protection/deprotection logic for chiral amino acid derivatives. The Fmoc group enables a controlled cycle of protection during handling and coupling, while the terminal carboxylic acid provides a consistent functional site for activation and incorporation into larger molecules. The stereochemical stability associated with the (3S,4S) centers supports manufacturing routes that require retention of configuration through sequential steps. Downstream, the material can be applied as a standardized input for producing stereodefined peptide fragments, peptidomimetic intermediates, and other chiral fine-chemical outputs that feed into further synthetic stages.

1. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

3. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

4. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

5. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction